A new study by Lyle Hood, assistant professor of mechanical engineering at The University of Texas at San Antonio (UTSA), describes a new device that could revolutionize the delivery of medicine to treat cancer as well as a host of other diseases and ailments.
Hood developed the device in partnership with Alessandro Grattoni, chair of the Department of Nanomedicine at Houston Methodist Research Institute.
“The problem with most drug-delivery systems is that you have a specific minimum dosage of medicine that you need to take for it to be effective,” Hood said. “There’s also a limit to how much of the drug can be present in your system so that it doesn’t make you sick.”
As a result of these limitations, a person who needs frequent doses of a specific medicine is required to take a pill every day or visit a doctor for injections. Hood’s creation negates the need for either of these approaches, because it’s a tiny implantable drug delivery system.
“It’s an implantable capsule, filled with medicinal fluid that uses about 5000 nanochannels to regulate the rate of release of the medicine,” Hood said. “This way, we have the proper amount of drugs in a person’s system to be effective, but not so much that they’ll harm that person.”
The capsule can deliver medicinal doses for several days or a few weeks. According to Hood, it can be used for any kind of ailment that needs a localized delivery over several days or a few weeks. This makes it especially tailored for treating cancer, while a larger version of the device, which was originally created by Grattoni, can treat diseases like HIV for up to a year.
“In HIV treatment, you can bombard the virus with drugs to the point that that person is no longer infectious and shows no symptoms,” Hood said. “The danger is that if that person stops taking their drugs, the amount of medicine in his or her system drops below the effective dose and the virus is able to become resistant to the treatments.”
The capsule, however, could provide a constant delivery of the HIV-battling drugs to prevent such an outcome. Hood noted it can also be used to deliver cortisone to damaged joints to avoid painful, frequent injections, and possibly even to pursue immunotherapy treatments for cancer patients.
“The idea behind immunotherapy is to deliver a cocktail of immune drugs to call attention to the cancer in a person’s body, so the immune system will be inspired to get rid of the cancer itself,” he said.
The current prototype of the device is permanent and injected under the skin, but Hood is working with Teja Guda, assistant professor of biomedical engineering, to collaborate on 3-D printing technology to make a new, fully biodegradable iteration of the device that could potentially be swallowed.
Receive an email update when we add a new DRUG DELIVERY CAPSULE article.
The Latest on: Drug-delivery capsule
via Google News
The Latest on: Drug-delivery capsule
- Smart Pills Market Research Projection By Technology, Research, Growth, Pharma, Effects, Segments, Demand, Sales, Revenue Analysis Forecast 2026on November 27, 2019 at 4:53 am
Based on the target area the market has been segmented into esophagus, stomach, small intestine and large intestine. Applications segment has been categorized into drug delivery, capsule endoscopy, ...
- Smart Pills Drug Delivery Market Analysis with Research Report 2019on November 26, 2019 at 9:30 pm
Click the link to get a Sample Copy of the Report: ...
- Oramed Patent Granted in Japan for Protease Inhibitor, a Key Component of Platform Technologyon November 21, 2019 at 4:05 pm
NEW YORK, Nov. 21, 2019 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (ORMP) (ORMP.TA) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems ...
- BioWorld MedTech Patent Highlights - Week 46on November 21, 2019 at 3:53 pm
Moving the slider causes capsule 2 to be fractured perpendicular to its length (figs 3 ... specializing in medical products especially drug delivery devices. It is headquartered in Baltimore, USA. The ...
- Coaxial E-Spun Fibers Open the Door to New Drug Delivery Channelson November 20, 2019 at 11:57 am
“The electrospun capsule can slowly release its payload ... Steckl point out that the fibers’ large surface area and custom properties make them well-suited for drug delivery. For example, patients ...
- Oramed Provides Highlights and Data From Its Phase IIb Oral Insulin Study Investor Eventon November 19, 2019 at 4:55 am
(www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, conducted an investor event and conference call yesterday, November 18 ...
- New microneedle insulin pill avoids injections, applies insulin to gut wallon October 9, 2019 at 9:51 pm
The capsule is coated with a polymer capable of resisting the ... safety tests on animal and human tissue to ensure that the penetration event allowed for drug delivery without causing a full ...
- Drug capsule could take sting out of insulin ingestionon October 8, 2019 at 1:31 am
Diabetics might one day ingest medication orally following the development of a drug capsule that carries insulin or other protein drugs safely into the harsh environment of the gastrointestinal tract ...
- New capsule could see end to insulin injections for those with diabeteson October 7, 2019 at 10:43 am
The new capsule is designed to withstand the acidic environment ... safety tests on animal and human tissue to ensure that the penetration event allowed for drug delivery without causing a full ...
via Bing News